...
机译:一种新的二芳基脲化合物D181通过靶向受体酪氨酸激酶和微管骨架,诱导G1和M期细胞周期停滞
Key Laboratory of Regenerative Biology and Institute of Chemical Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, #190 Kaiyuan Road, Guangzhou Science Park, Guangzhou, Guangdong Province, 510530, China;
Key Laboratory of Regenerative Biology and Institute of Chemical Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, #190 Kaiyuan Road, Guangzhou Science Park, Guangzhou, Guangdong Province, 510530, China;
Key Laboratory of Regenerative Biology and Institute of Chemical Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, #190 Kaiyuan Road, Guangzhou Science Park, Guangzhou, Guangdong Province, 510530, China;
School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China;
School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, Ch;
D181; Receptor tyrosine kinase; G1/M arrest; Tubulin polymerization;
机译:一种新的二芳基脲化合物D181通过靶向受体酪氨酸激酶和微管骨架,诱导G1和M期细胞周期停滞。
机译:SUCI02抑制erbB-2酪氨酸激酶受体信号传导途径,并阻止乳腺癌细胞G1期的细胞周期。
机译:厄洛替尼是一种有效的表皮生长因子受体酪氨酸激酶抑制剂,可诱导p27KIP1上调和核易位,并与人类非小细胞肺癌细胞系中的细胞生长抑制和G1 / S期阻滞有关
机译:受体酪氨酸激酶亚类III膜结合同种型配体的作用在诱导早期造血祖细胞的诱导自我更新中
机译:细胞周期的小分子调节:诱导G1期和M期细胞周期停滞及其作用方式表征的抗癌化合物的发现。
机译:回复:Ling YHLi TYuan ZHaigentz MJr.Weber TK和Perez-Soler R(2007)厄洛替尼一种有效的表皮生长因子受体酪氨酸激酶抑制剂可诱导p27KIP1上调和缔合中的核转运人非小细胞肺癌细胞系中细胞生长抑制和G1 / S期阻滞的研究Mol Pharmacol 72:248–258; doi:10.1124 / mol.107.034827
机译:Re:Ling Yh,Li T,Yuan Z,Haigentz M,Jr.,Weber Tk和Perez-Soler R(2007)erlotinib,一种有效的表皮生长因子受体酪氨酸激酶抑制剂,诱导P27KIP1结社上调和核易位具有细胞生长抑制和人类非小细胞肺癌细胞系的G1 / S期阻滞。 mol pharmacol 72:248-258; DOI:10.1124 / mol.107.034827